367 related articles for article (PubMed ID: 15634647)
1. Role of human copper transporter Ctr1 in the transport of platinum-based antitumor agents in cisplatin-sensitive and cisplatin-resistant cells.
Song IS; Savaraj N; Siddik ZH; Liu P; Wei Y; Wu CJ; Kuo MT
Mol Cancer Ther; 2004 Dec; 3(12):1543-9. PubMed ID: 15634647
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin stabilizes a multimeric complex of the human Ctr1 copper transporter: requirement for the extracellular methionine-rich clusters.
Guo Y; Smith K; Petris MJ
J Biol Chem; 2004 Nov; 279(45):46393-9. PubMed ID: 15326162
[TBL] [Abstract][Full Text] [Related]
3. The roles of copper transporters in cisplatin resistance.
Kuo MT; Chen HH; Song IS; Savaraj N; Ishikawa T
Cancer Metastasis Rev; 2007 Mar; 26(1):71-83. PubMed ID: 17318448
[TBL] [Abstract][Full Text] [Related]
4. Factors affecting sensitivity to antitumor platinum derivatives of human colorectal tumor cell lines.
Kitada N; Takara K; Minegaki T; Itoh C; Tsujimoto M; Sakaeda T; Yokoyama T
Cancer Chemother Pharmacol; 2008 Sep; 62(4):577-84. PubMed ID: 18030470
[TBL] [Abstract][Full Text] [Related]
5. The expression of copper transporters associated with the ototoxicity induced by platinum-based chemotherapeutic agents.
Perde-Schrepler M; Fischer-Fodor E; Virag P; Brie I; Cenariu M; Pop C; Valcan A; Gurzau E; Maniu A
Hear Res; 2020 Mar; 388():107893. PubMed ID: 32006874
[TBL] [Abstract][Full Text] [Related]
6. Contributions of rat Ctr1 to the uptake and toxicity of copper and platinum anticancer drugs in dorsal root ganglion neurons.
Liu JJ; Kim Y; Yan F; Ding Q; Ip V; Jong NN; Mercer JF; McKeage MJ
Biochem Pharmacol; 2013 Jan; 85(2):207-15. PubMed ID: 23123662
[TBL] [Abstract][Full Text] [Related]
7. A re-evaluation of the role of hCTR1, the human high-affinity copper transporter, in platinum-drug entry into human cells.
Ivy KD; Kaplan JH
Mol Pharmacol; 2013 Jun; 83(6):1237-46. PubMed ID: 23543413
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the high-affinity copper transporter (hCtr1) expression by cisplatin and heavy metals.
Liang ZD; Long Y; Chen HH; Savaraj N; Kuo MT
J Biol Inorg Chem; 2014 Jan; 19(1):17-27. PubMed ID: 24132751
[TBL] [Abstract][Full Text] [Related]
9. Overcoming platinum drug resistance with copper-lowering agents.
Chen HH; Kuo MT
Anticancer Res; 2013 Oct; 33(10):4157-61. PubMed ID: 24122978
[TBL] [Abstract][Full Text] [Related]
10. The copper influx transporter human copper transport protein 1 regulates the uptake of cisplatin in human ovarian carcinoma cells.
Holzer AK; Samimi G; Katano K; Naerdemann W; Lin X; Safaei R; Howell SB
Mol Pharmacol; 2004 Oct; 66(4):817-23. PubMed ID: 15229296
[TBL] [Abstract][Full Text] [Related]
11. Copper transporters and the cellular pharmacology of the platinum-containing cancer drugs.
Howell SB; Safaei R; Larson CA; Sailor MJ
Mol Pharmacol; 2010 Jun; 77(6):887-94. PubMed ID: 20159940
[TBL] [Abstract][Full Text] [Related]
12. Role of copper transporters in resistance to platinating agents.
Rabik CA; Maryon EB; Kasza K; Shafer JT; Bartnik CM; Dolan ME
Cancer Chemother Pharmacol; 2009 Jun; 64(1):133-42. PubMed ID: 18998134
[TBL] [Abstract][Full Text] [Related]
13. Reactivity of platinum-based antitumor drugs towards a Met- and His-rich 20mer peptide corresponding to the N-terminal domain of human copper transporter 1.
Wu Z; Liu Q; Liang X; Yang X; Wang N; Wang X; Sun H; Lu Y; Guo Z
J Biol Inorg Chem; 2009 Nov; 14(8):1313-23. PubMed ID: 19669174
[TBL] [Abstract][Full Text] [Related]
14. Copper transporter 1 in human colorectal cancer cell lines: Effects of endogenous and modified expression on oxaliplatin cytotoxicity.
Cui H; Zhang AJ; McKeage MJ; Nott LM; Geraghty D; Guven N; Liu JJ
J Inorg Biochem; 2017 Dec; 177():249-258. PubMed ID: 28551160
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells.
Samimi G; Safaei R; Katano K; Holzer AK; Rochdi M; Tomioka M; Goodman M; Howell SB
Clin Cancer Res; 2004 Jul; 10(14):4661-9. PubMed ID: 15269138
[TBL] [Abstract][Full Text] [Related]
16. Platinum transfer from hCTR1 to Atox1 is dependent on the type of platinum complex.
Wu X; Yuan S; Wang E; Tong Y; Ma G; Wei K; Liu Y
Metallomics; 2017 May; 9(5):546-555. PubMed ID: 28383086
[TBL] [Abstract][Full Text] [Related]
17. Predictive and prognostic value of human copper transporter 1 (hCtr1) in patients with stage III non-small-cell lung cancer receiving first-line platinum-based doublet chemotherapy.
Chen HH; Yan JJ; Chen WC; Kuo MT; Lai YH; Lai WW; Liu HS; Su WC
Lung Cancer; 2012 Feb; 75(2):228-34. PubMed ID: 21788094
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the cellular pharmacology of cisplatin and its analogs by the copper exporters ATP7A and ATP7B.
Samimi G; Katano K; Holzer AK; Safaei R; Howell SB
Mol Pharmacol; 2004 Jul; 66(1):25-32. PubMed ID: 15213293
[TBL] [Abstract][Full Text] [Related]
19. Comparison between copper and cisplatin transport mediated by human copper transporter 1 (hCTR1).
Du X; Wang X; Li H; Sun H
Metallomics; 2012 Jul; 4(7):679-85. PubMed ID: 22552365
[TBL] [Abstract][Full Text] [Related]
20. Role of the human high-affinity copper transporter in copper homeostasis regulation and cisplatin sensitivity in cancer chemotherapy.
Kuo MT; Fu S; Savaraj N; Chen HH
Cancer Res; 2012 Sep; 72(18):4616-21. PubMed ID: 22962276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
